充血性心力衰竭病人心肌细胞凋亡及Fas/FasL系统的调节作用

被引:7
作者
张顺业
孙宗全
机构
[1] 华中科技大学同济医学院协和医院心脏外科
关键词
心力衰竭,充血性; 心肌; 脱噬作用; caspase-3; Fas; FasL; 氧化性应激;
D O I
暂无
中图分类号
R541.61 [];
学科分类号
摘要
目的 观察充血性心力衰竭 (CHD)病人心肌细胞是否存在细胞凋亡以及Fas/FasL蛋白、caspase 3和心肌氧化性应激的调节作用。方法 实验以进行常规CPB的无肺动脉高压的ASD病人为对照组 (n =5 ) ,以合并CHD的RHD病人为观察组(n =5 )。体外循环术前留取右心室标本。用原位TUNEL技术检测凋亡心肌细胞。用流式细胞仪技术测定右心室Fas和FasL蛋白表达。用Z DEVD AMC底物降解法和TBARS方法分别测定右心室心肌caspase 3酶活性和脂质过氧化物含量(MDA)。结果 RHD病人右心室心肌细胞凋亡数、caspase 3活性、MDA以及Fas、FasL蛋白表达均明显高于ASD病人 (P分别为 0 0 2 6 ,0 0 13,0 0 0 2 ,0 0 0 4和 0 0 33)。结论 心肌细胞凋亡参与CHD的病理生理过程。CHD病人的心肌细胞凋亡与心肌细胞Fas、FasL蛋白表达上调、caspase 3激活以及心肌氧化性应激增高有关
引用
收藏
页码:492 / 493
页数:2
相关论文
共 13 条
[1]  
Elevated DNase I levels in human idiotic cardiomyopathy: an indicator of apoptosis. Yao M,Keogh A,Sprant P,et al. Journal of Molecular and Cellular Cardiology . 1996
[2]  
The Fas/FasL ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. Ishiyama S,Hiroe M,Nishikawa T,et al. J Immunol . 1998
[3]  
The cardiac Fas(APO-1 /CD95) receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Woller KC,Heineke J,Watermann J,et al. Circulation . 2000
[4]  
Apoptosis in the failing human heart. Olivetti G,Abbi R,Quaini F,et al. The New England Journal of Medicine . 1996
[5]  
Apoptosis in end-stage heart failure. Narula J,Haider N,Virmani R,et al. The New England Journal of Medicine . 1996
[6]  
The CD95 (APO1/Fas) receptor activates NF-κB independently of its cytotoxic function. Ponton A,Clement MV,Stamenkovic I,et al. Journal of Biological Chemistry . 1996
[7]  
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[8]  
Signaling mechanism and oxidative stress in apoptosis. Slater AFG,Stefan C,Nobel I,et al. Toxicology Letters . 1995
[9]  
Elevated circulation levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Yamaguchi S,Yamaoka M,Okuyama M,et al. The American Journal of Cardiology . 1999
[10]  
Cell death in acromegalic cardiomyopathy. Frustaci A,Chimenti C,Setogguchi M,et al. Circulation . 1999